摘要
目的探讨尤瑞克林在糖尿病并进展性脑梗死治疗中的效果。方法选取该院2017年3月—2018年3月收治的糖尿病合并进展性脑梗死患者88例,随机分为2组各44例,对照组给予红花黄色素,观察组在对照组的基础上给予尤瑞克林,比较疗效。结果观察组总有效率为90.9%,显著优于对照组77.3%(P<0.05);治疗后观察组FPG(6.0±0.5)mmol/L、NIHSS评分(4.65±1.91)分,显著低于对照组(P<0.05)。结论糖尿病并进展性脑梗死患者采用尤瑞克林治疗,可有效改善患者神经功能,效果显著,值得应用。
Objective To study the effect of urinary kallikrein in treatment of diabetes combined with progressive cerebral infarction. Methods 88 cases of patients with diabetes combined with progressive cerebral infarction admitted and treated in our hospital from March 2017 to March 2018 were selected and randomly divided into two groups with 44 cases in each, the control group were treated with carthamin yellow, while the observation group were treated with urinary kallikrein on the basis of the control group, and the curative effect was compared between the two groups. Results The total effective rate in the observation group was obviously better than that in the control group（90.9% vs 77.3%）（P〈0.05）, and the FPG（6.0±0.5）mmol/L, NIHSS（4.65±1.9）, in the observation group after treatment were obviously lower than those in the control group（P〈0.05）. Conclusion The urinary kallikrein in treatment of diabetes combined with progressive cerebral infarction can effectively improve the nerve function, and the effect is obvious, which is worth application.
作者
徐宝林
XU Bao-lin(Department of Neurology,FAW General Hospital,Changchun,Jilin Province,130000 China)
出处
《糖尿病新世界》
2018年第9期99-100,共2页
Diabetes New World Magazine
关键词
尤瑞克林
糖尿病
进展性
脑梗死
疗效
Urinary kallikrein
Diabetes
Progressive
Cerebral infraction
Curative effect
